Non-Current Assets

Equity Method Investments

Southern Company Equity Method Investments decreased by 4.6% to $1.38B in Q3 2023 compared to the prior quarter. Year-over-year, this metric grew by 6.5%, from $1.29B to $1.38B. Over 2 years (FY 2020 to FY 2022), Equity Method Investments shows relatively stable performance with a 2.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.

Detailed definition

These are investments in entities where the company exercises significant influence but does not have full control. The...

Peer comparison

Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.

Metric ID: equity_method_investments

Historical Data

8 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q3 '23
Value$1.29B$1.28B$1.28B$1.29B$1.31B$1.29B$1.44B$1.38B
QoQ Change-0.7%+0.3%+0.9%+0.9%-1.0%+11.7%-4.6%
YoY Change+1.4%+1.1%+12.6%+6.5%
Range$1.28B$1.44B
CAGR+3.9%
Avg YoY Growth+5.4%
Median YoY Growth+4.0%

Frequently Asked Questions

What is Southern Company's equity method investments?
Southern Company (SO) reported equity method investments of $1.38B in Q3 2023.
How has Southern Company's equity method investments changed year-over-year?
Southern Company's equity method investments increased by 6.5% year-over-year, from $1.29B to $1.38B.
What is the long-term trend for Southern Company's equity method investments?
Over 2 years (2020 to 2022), Southern Company's equity method investments has grown at a 2.9% compound annual growth rate (CAGR), from $1.36B to $1.44B.
What does equity method investments mean?
The value of investments in other companies where the firm has significant influence but not total control.